Background:
Spinal arteriovenous malformations (AVMs) are a rare and enigmatic disease entity. These lesions can be a significant cause of myelopathy and their initial symptoms mainly include sensory loss and motor weakness. The treatment of spinal AVMs has improved tremendously. However, the choice between surgical treatment and embolization remains a matter of debate.